Daniela Liccardo Selected Research

Daniela Liccardo Research Topics

Disease

14	Heart Failure 01/2023 - 04/2012
7	Non-alcoholic Fatty Liver Disease 01/2016 - 09/2013
6	Insulin Resistance 02/2015 - 01/2014
5	Fibrosis (Cirrhosis) 09/2022 - 09/2013
5	Cardiovascular Diseases (Cardiovascular Disease) 07/2022 - 04/2012
5	Liver Diseases (Liver Disease) 01/2022 - 01/2015
5	Myocardial Infarction 01/2021 - 01/2013
4	Infections 04/2024 - 01/2019
4	Ischemia 01/2023 - 10/2013
3	Inflammation (Inflammations) 09/2022 - 01/2015
3	Obesity 01/2015 - 04/2014
2	Infarction (Infarctions) 01/2023 - 02/2014
2	End Stage Liver Disease 01/2021 - 10/2020
2	Liver Cirrhosis (Hepatic Cirrhosis) 01/2020 - 01/2016
1	Hepatitis 04/2024
1	Stroke (Strokes) 01/2023
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2023
1	Heart Diseases (Heart Disease) 01/2023
1	Left Ventricular Dysfunction 01/2023
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2023
1	Methylmalonic acidemia 01/2023
1	Inborn Errors Metabolism (Inborn Errors of Metabolism) 01/2023
1	COVID-19 09/2022
1	Sarcopenia 01/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 08/2021
1	Bacteremia 06/2021
1	Ethylmalonic encephalopathy 01/2021
1	Cicatrix (Scar) 01/2021
1	Cholangitis 10/2020
1	Biliary Atresia 10/2020
1	Cholestasis 08/2020
1	Periodontitis 01/2020
1	Dysbiosis 01/2020
1	Vitamin D Deficiency 01/2020
1	Hyperaldosteronism (Conn Syndrome) 01/2019
1	Pathologic Constriction (Stenosis) 12/2018
1	Biliary Liver Cirrhosis (Primary Biliary Cirrhosis) 12/2018
1	Chronic Renal Insufficiency 04/2016
1	Chronic Obstructive Pulmonary Disease (COPD) 04/2016
1	Cardiomegaly (Heart Hypertrophy) 03/2016

Drug/Important Bio-Agent (IBA)

10	Adrenergic Receptors (Adrenergic Receptor)IBA 07/2022 - 05/2012
6	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2018 - 04/2012
4	Adrenergic Agents (Adrenergic Drugs)IBA 01/2023 - 04/2012
4	AldosteroneIBA 09/2022 - 02/2014
3	Proteins (Proteins, Gene)FDA Link 04/2016 - 10/2013
3	CatecholaminesIBA 02/2016 - 04/2012
2	Transaminases (Aminotransferases)IBA 04/2024 - 04/2014
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 09/2022
2	VitaminsIBA 01/2020 - 11/2019
2	Phosphotransferases (Kinase)IBA 01/2019 - 02/2016
2	Brain Natriuretic Peptide (Natrecor)FDA Link 04/2016 - 02/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2016 - 11/2014
2	Insulin (Novolin)FDA Link 02/2015 - 11/2014
2	LipidsIBA 01/2015 - 01/2014
2	CytokinesIBA 01/2015 - 01/2014
2	Neurotransmitter Agents (Neurotransmitter)IBA 02/2014 - 04/2012
1	NucleoproteinsIBA 04/2024
1	AntibodiesIBA 04/2024
1	Metoprolol (Toprol-XL)FDA LinkGeneric 01/2023
1	Alanine (L-Alanine)FDA Link 01/2023
1	Calcineurin InhibitorsIBA 01/2023
1	N,N',N'- tris(2- hydroxyethyl)- 1,3,5- benzenetricarboxamideIBA 01/2023
1	Lactic Acid (Lactate)FDA LinkGeneric 01/2023
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2023
1	tropomyosin kinaseIBA 01/2023
1	Hormones (Hormone)IBA 09/2022
1	Galectin 3 (LGALS3)IBA 09/2022
1	Troponin IIBA 09/2022
1	CeramidesIBA 04/2022
1	Estrogens (Estrogen)FDA Link 04/2022
1	sphingosine 1-phosphate (sphingosine-1-phosphate)IBA 04/2022
1	serum P-component (CIt)IBA 01/2022
1	Tacrolimus (Prograf)FDA LinkGeneric 01/2022
1	pyrrolidin-3-yl-methanesulfonic acid (PMSA)IBA 01/2022
1	Atrial Natriuretic Factor (ANF)IBA 01/2021
1	BilirubinIBA 10/2020
1	SteroidsIBA 10/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2020
1	7-ketocholesterolIBA 08/2020
1	OxysterolsIBA 08/2020
1	vitamin E drug combination vitamin AIBA 01/2020
1	VaccinesIBA 11/2019
1	Hepatitis B Core AntigensIBA 11/2019
1	ArrestinsIBA 07/2019
1	G-Protein-Coupled Receptor KinasesIBA 07/2019
1	Protein CIBA 01/2019
1	Surface-Active Agents (Surfactants)IBA 01/2019
1	salicylhydroxamic acid (SHAM)IBA 01/2018
1	Peptides (Polypeptides)IBA 02/2016

Therapy/Procedure

13	Liver Transplantation 01/2023 - 09/2013
8	Therapeutics 07/2022 - 05/2012
2	Transplantation 01/2023 - 12/2018
2	Oral Hygiene (Dental Hygiene) 06/2021 - 01/2020
2	Drug Therapy (Chemotherapy) 12/2014 - 04/2012
1	Denervation 01/2023
1	Ligation 01/2023
1	Kidney Transplantation 01/2023
1	Nutritional Support (Artificial Feeding) 01/2022
1	Hepatic Portoenterostomy 10/2020
1	Caloric Restriction 01/2018